Iram Malik1, Muhammad Atif2, Fatima Riaz1, Saima Asghar1, Nafees Ahmad3. 1. Department of Pharmacy, The Islamia University of Bahawalpur, Railway Road Campus, Bahawalpur, 63100, Pakistan. 2. Department of Pharmacy, The Islamia University of Bahawalpur, Railway Road Campus, Bahawalpur, 63100, Pakistan. pharmacist_atif@yahoo.com. 3. Faculty of Pharmacy and Health Sciences, University of Balochistan, Quetta, Pakistan.
Abstract
BACKGROUND: The unavailability of appropriate pediatric drug pack size is a global issue. Antibiotics are the lifesaving and most frequently prescribed therapeutic agents given to pediatrics. The objective of this study was to assess the compliance of pediatric antibiotic pack size with the standard dosage regimen. METHODS: A descriptive study design was employed. Data were collected from a community pharmacy in Bahawalpur, Pakistan, between August 1, 2017, and September 30, 2017. Five most commonly prescribed antibiotics were selected and calculations were made to check the appropriateness of packaging size by comparing the quantity of product in the available pack with the dosage regimen recommended by the British National Formulary for Children (BNFC). RESULTS: Only 16 clarithromycin, 9 amoxicillin, 1 cefotaxime, and 1 metronidazole packaging sizes were sufficient to meet the dosage regimen for treatment. None of the available pack sizes for gentamicin matched the recommended duration of treatment. The study findings revealed that the available pack sizes either had leftover or a shortfall of antibiotic formulation. Highly inappropriate dosage forms (containing either excess and less quantity) of antibiotics were intravenous infusions and oral suspensions. CONCLUSION: The study concluded that the packaging sizes of antibiotics failed to supply the recommended dosage regimen to pediatrics for common indications. This may contribute to development of antibiotic resistance among pediatric patients. Health policy makers should devise strict rules and regulations to ensure the availability of child-specific antibiotic pack sizes.
BACKGROUND: The unavailability of appropriate pediatric drug pack size is a global issue. Antibiotics are the lifesaving and most frequently prescribed therapeutic agents given to pediatrics. The objective of this study was to assess the compliance of pediatric antibiotic pack size with the standard dosage regimen. METHODS: A descriptive study design was employed. Data were collected from a community pharmacy in Bahawalpur, Pakistan, between August 1, 2017, and September 30, 2017. Five most commonly prescribed antibiotics were selected and calculations were made to check the appropriateness of packaging size by comparing the quantity of product in the available pack with the dosage regimen recommended by the British National Formulary for Children (BNFC). RESULTS: Only 16 clarithromycin, 9 amoxicillin, 1 cefotaxime, and 1 metronidazole packaging sizes were sufficient to meet the dosage regimen for treatment. None of the available pack sizes for gentamicin matched the recommended duration of treatment. The study findings revealed that the available pack sizes either had leftover or a shortfall of antibiotic formulation. Highly inappropriate dosage forms (containing either excess and less quantity) of antibiotics were intravenous infusions and oral suspensions. CONCLUSION: The study concluded that the packaging sizes of antibiotics failed to supply the recommended dosage regimen to pediatrics for common indications. This may contribute to development of antibiotic resistance among pediatric patients. Health policy makers should devise strict rules and regulations to ensure the availability of child-specific antibiotic pack sizes.
Entities:
Keywords:
British National Formulary for Children; antibiotic pack sizes; antibiotic resistance; compliance; irrational antibiotic use; leftover medicine; pediatric dosage regimen; pediatric formulations
Authors: Muhammad Atif; Waqar Ahmed; Muhammad Nouman Iqbal; Nafees Ahmad; Wajiha Ahmad; Iram Malik; Yaser Mohammed Al-Worafi Journal: Front Med (Lausanne) Date: 2022-03-01